Pure Global AI
ANVISA registration 10033121010Active

GLYCATED HEMOGLOBIN (HbA1C)

ANVISA Registration Number: 10033121010BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDABECKMAN COULTER INC.Risk Class II
Device names
Technical name
GLYCATED HEMOGLOBIN (HbA1C)
PT: HEMOGLOBINA GLICADA (HbA1C)
Commercial name
HbA1c Advanced
Risk class
Class II
Registration details
Registration Number
10033121010
Process Number
25351475100201955
CNPJ
42160812000144
Company information
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Nov 11, 2019
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10033121010 and manufactured by BECKMAN COULTER INC.. The registration is held by BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.